Start of Invitation of Presenters to MEDTEC INNOVATION Pitch by Universities/Businesses/Hospitals

Pitch meeting to be held to generate Japanese medical unicorns in Nihonbashi, the representative location of healthcare innovations in Japan

Life Science Innovation Network Japan, Inc. (Head office: Nihonbashi-Honcho, Chuo-ku, Tokyo; Chairman of the Board: Hideyuki Okano; hereinafter "LINK-J"), Japanese Organization for Medical Device Development, Inc. (CEO: Takahiro Uchida; hereinafter "JOMDD"), MedVenture Partners, Inc. (President & CEO: Hajime Oshita; hereinafter "MedVenture"), and US-Japan Medtech Frontiers (Chairmen: Jack Moorman; hereinafter "USJMF") are starting to invite participants to the following pitch event today.

Guidelines for applicants : MEDTEC INNOVATION Pitch by Universities/Businesses/Hospitals

Profiles of pitch judges

Takahiro (Taka) Uchida, MD, PhD, MSc,
Founder and CEO of the Japanese Organization for Medical Device Development, Inc. (JOMDD), the first incubator for medical devices and healthcare in Japan. Taka is a specialist for cardiology and internal medicine in Japan. He graduated the Harvard School of Public Health with a master degree in Epidemiology and completed the General Management Program at Harvard Business School. He is the first Japanese medical officer/reviewer at the U.S. Food and Drug Administration, Center for Devices and Radiological Health.
After succeed as a Medical Director at Boston Scientific Corporation, Taka worked as a consultant to support multiple medtech startups in the Bay area of U.S.A.
Taka works as a visiting professor at Osaka University since 2018. He also holds several academic roles, for example, committee member/review board/advisory for the Ministry of Health, Labour, and Welfare, Japan Agency for Medical Research and Development, etc.

Hajime Oshita, President & CEO of MedVenture Partners, Inc.

Graduated from Osaka University of Foreign Studies and Hosei University Graduate School of Business Administration. Has more than 20 years' experience in the medical device industry, including investment at venture capital firms and business development at multiple medical device companies. Started his career in the medical device industry at Japan Lifeline Co., Ltd. and was in charge of negotiations with medical device start-ups in the U.S.A.: his first contact with the venture investment world.
Subsequently in charge of investment in overseas medical device start-ups at ITX. Led the final round of Fox Hollow Technologies, which achieved a valuation of 1.4 billion dollars at its peak after IPO. From 2005, spent 5 years in Silicon Valley as a local hire and engaged in medical device investment s in the U.S.A. . Numerous medical devices have been developed by start-ups in which he invested, which are currently used in the world's most advanced medical practices, such as the Flow Diverter for treating brain aneurysms. The track record of EXIT includes Chestnut Medical, Cardiovascular Systems, Inc., C2 Therapeutics, and Biomedical Solutions, Inc. In 2013, started a medical device focused fund of 6 billion yen and has been actively investing in medical device start-ups both in Japan and U.S..

Kirk Zeller　Board Member, US Japan Medtech Frontiers, Founder, Silicon Prairie Center Partner, Nichibei Medtech Advisors, LLC Board Member, Co-Founder, MedMarket Access, LLC

Kirk Zeller, DBA is a medical device entrepreneur and founder of the Silicon Prairie Center, a unique entrepreneur live and work community which incubates capital efficient start-ups. Kirk's career as well as his masters and doctorate research have focused on medical device start-ups and Kirk is currently co-founder of several companies including two incubated at the Silicon Prairie Center. Kirk started his career as a heart valve sales rep in Japan and has lived, worked, and studied in the US, Europe, and Asia.

Hiroyuki Hasegawa, Executive Officer of Mitsubishi UFJ Capital Co., Ltd.
Joined Daiichi Pharmaceutical Co., Ltd. (currently: Daiichi Sankyo Co., Ltd.) in 1994. Hasegawa was assigned to the post-marketing surveillance department and took charge of the areas of infectious diseases and oncology. He joined UFJ Capital Co., Ltd. (currently: Mitsubishi UFJ Capital Co., Ltd.) in 2004. Since 2013, he has been engaged in open innovation activities in collaboration with Daiichi Sankyo Co., Ltd. based on the results of academic research funded by the OiDE Fund. Hasegawa has promoted investment efforts using the Mitsubishi UFJ Life Science No.1 Fund (10 billion yen) and No. 2 Fund (10 billion yen) established in 2017 and 2019 respectively. Currently, he is an outside director of Kamui Pharma, Inc., Chordia Therapeutics, Inc., and Veritas In Silico, Inc., as well as a "medical

field" industry-academia fellow at the Graduate School of Medicine, Kyoto University, under the Industry-Academia Collaboration Initiative.

Outline of 2nd MEDTEC INNOVATION - Symposium and Pitch

Outline

Date: November 5, 2019, Tuesday,
Location: Nihonbashi Mitsui Hall (2-1, Nihonbashi-muromachi 2-chome, Chuo-ku, Tokyo 103-0022)
Hosted by: Life Science Innovation Network Japan, Inc. (LINK-J)
Co-hosted by: Japanese Organization for Medical Device Development, Inc. (JOMDD), MedVenture Partners, Inc., and US-Japan Medtech Frontiers (USJMF)
Expected visitors: Around 300 including journalists and people concerned with the medical device industry

About Life Science Innovation Network Japan, Inc. (LINK-J)

LINK-J is a general incorporated association established by Mitsui Fudosan and volunteers from academic circles. With its base in the Nihonbashi area, where a number of pharmaceutical companies cluster, LINK-J aims to promote open innovation in the life science realm through industry-government-academia cooperation and extend support to the creation of new industries. LINK-J will accelerate interdisciplinary exchanges at human/ technology field, where all sciences are combined, ranging from medicine to science, further more, engineering, new technologies, such as information and communication technology (ICT) or artificial intelligence (AI).

Overview of Japanese Organization for Medical Device Development, Inc. (JOMDD)

Japanese Organization for Medical Device Development, Inc. is the first business incubator in Japan that cooperates with academia and startups in Japan to commercialize medical devices and other products. It invests money in and provides support to research institutions and businesses around Japan to grow Japan-made products that can compete globally; for example, the outsourcing of projects of the Japan Medical Association, universities, and local administrations such as Kanagawa and Kobe. Its' track record includes investment in and support for the start-up from Kumamoto that is developing a pain treatment device and the start-up from the University of Electro-Communications that is developing rehabilitation equipment and other devices using robotics technology.
https://jomdd.com/

Overview of MedVenture Partners, Inc.
MedVenture Partners, Inc. invests in the life science field, including medical devices, at an early stage so as to contribute to the development of the medical device business incubation and the industrial base for medical Device in Japan through a sufficient track record of investment in medical device start-ups and business incubation in Japan and the U.S.A., including Silicon Valley, experience in clinical settings and medical research in Japan, and their global network.
http://www.medvp.co.jp/

Overview of US-Japan Medtech Frontiers(USJMF)
USJMF is a nonprofit corporation based in Silicon Valley whose mission is to share best practices for medical device innovation and promote networking and cooperation between US and Japanese medical device organizations.
https://www.usjmf.net/